Polaris Venture Management Co. V as of March 31, 2016
Portfolio Holdings for Polaris Venture Management Co. V
Polaris Venture Management Co. V holds 9 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Trevena | 21.1 | $22M | 2.7M | 8.27 | |
| T2 Biosystems | 19.0 | $20M | 2.0M | 9.86 | |
| Genocea Biosciences | 14.6 | $15M | 2.0M | 7.74 | |
| Ocular Therapeutix (OCUL) | 11.3 | $12M | 1.2M | 9.66 | |
| Pulmatrix | 10.1 | $11M | 3.6M | 2.93 | |
| Cerulean Pharma | 8.5 | $8.9M | 3.3M | 2.71 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 6.9 | $7.2M | 1.8M | 3.94 | |
| Fate Therapeutics (FATE) | 4.2 | $4.5M | 2.5M | 1.80 | |
| Bind Therapeutics | 4.2 | $4.4M | 2.0M | 2.20 |
